The Evolution of Pediatric Soft Tissue Sarcoma Classification in the Last 50 Years
- 1 November 2015
- journal article
- research article
- Published by SAGE Publications in Pediatric and Developmental Pathology
- Vol. 18 (6) , 481-494
Abstract
This review discusses the history of the classification of soft tissue sarcomas in children and adolescents, the current transition toward integration of morphology and molecular genetics as new entities emerge, and future perspectives.Keywords
This publication has 83 references indexed in Scilit:
- PAX3/FOXO1 Fusion Gene Status Is the Key Prognostic Molecular Marker in Rhabdomyosarcoma and Significantly Improves Current Risk StratificationJournal of Clinical Oncology, 2012
- A new subtype of bone sarcoma defined by BCOR-CCNB3 gene fusionNature Genetics, 2012
- Pathology of peripheral nerve sheath tumors: diagnostic overview and update on selected diagnostic problemsActa Neuropathologica, 2012
- Neurogenic Tumors of Soft TissuePediatric and Developmental Pathology, 2012
- High prevalence of CIC fusion with double‐homeobox (DUX4) transcription factors in EWSR1‐negative undifferentiated small blue round cell sarcomasGenes, Chromosomes and Cancer, 2011
- Adult-type Fibrosarcoma: A Reevaluation of 163 Putative Cases Diagnosed at a Single Institution Over a 48-year PeriodAmerican Journal of Surgical Pathology, 2010
- Fusion Gene-Negative Alveolar Rhabdomyosarcoma is Clinically and Molecularly Indistinguishable from Embryonal RhabdomyosarcomaJournal of Clinical Oncology, 2010
- Identification of p53 as a strong predictor of survival for patients with malignant peripheral nerve sheath tumorsNeuro-Oncology, 2009
- Molecular Classification of Rhabdomyosarcoma—Genotypic and Phenotypic Determinants of DiagnosisThe American Journal of Pathology, 2009
- Loss of INI1 expression defines a unique subset of pediatric undifferentiated soft tissue sarcomasLaboratory Investigation, 2008